No Data
Leerink Partners Maintains Quanterix(QTRX.US) With Buy Rating
Leerink Partners Sticks to Its Buy Rating for Quanterix (QTRX)
Sector Update: Health Care Stocks Steady Pre-Bell Tuesday
Quanterix Stock Drops 7% on Deal to Buy Emission
Quanterix Will Use Cash on Hand to Acquire EMISSION for $10M, With Additional $10M Payable Upon Completion of Certain Technical Milestones >QTRX
Quanterix Expects the Transaction Will Close in Jan >QTRX